Study of the use of Pregabalin
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Poster
- By: FERNANDEZ, Leonardo (Colegio de Farmacéuticos de Buenos Aires Lomas de Zamora, filial Lomas de Zamora, Lomas de Zamora, Argentina)
- Co-author(s): Leonardo jorge Fernandez:|Veronica Gregorio:|Marcela De Caria:|Karina Perrotta:|Rita Metz:
Pregabalin is anantiepileptic drug with structural analogue of GABA. Its therapeutic indications approved by FDA,only in adults are: combined treatment of partial seizures , treatment of neuropathic pain, treatment of generalized anxiety disorder(GAD)and fibromyalgia. The latter use is not approved by the EMA
By a cross-sectional study conducted.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.